News

David Roche of Quantum Strategy says a weaker dollar will drive 10-year yields to 5.5%, which will threaten the dollar's ...
For years, Roche has been increasing medicine production in the United States. That could pay off for the drug maker as ...
As the nearly 130-year-old pharmaceutical company consolidated its CRM systems, it cut down on vendor costs and paved the way ...
The biotech company Roche is receiving support towards its efforts to advance cancer diagnosis and digital pathology ...
Swiss drugmaker Roche is petitioning the U.S. government in direct talks for import tariff exemptions, arguing the products ...
Roche said on Tuesday it would invest $50 billion in the United States over the next five years, creating more than 12,000 ...
The move will also create 12,000 new jobs across the United States, with 6,500 in construction and 1,000 at “new and expanded ...
April 22 (UPI) -- Biotechnology giant Roche said it will invest $50 billion into the United States over the next five years.
Roche posted a Q1 revenue beat, with strong contributions from Phesgo, Xolair, and Polivy, despite larger products lagging.
The pharma giant said the investment would create more than 12,000 jobs, as it joins rival Novartis in expanding its ...
Roche posted higher-than-expected first-quarter sales, driven by robust demand for its key drugs, as the company takes active ...
Seductive Reasoning,” a flop that preceded the Roches’ debut, has a fluctuating sonic palette, contributions from Paul Simon ...